MedRhythms Secures $25M Series B to Advance Digital Therapeutics Platform

July 29, 2021

7 Views

MedRhythms is developing prescription digital therapeutics that use sensors, software, and music to measure and improve walking for patients with a neurologic injury or disease.

MedRhythms Secures $25M Series B to Advance Digital Therapeutics Platform

Better Therapeutics Co-Founder Speaks on SPACs and the Growing PDT Market

Success Starts Early: Tips for Building a Thriving Medtech Startup
Boston Scientific Packaging Engineer Earns Rising Leader Honor
Hottest Takes from Medical Device Professionals
24 Medtech Voices to Follow in 2024
EndoQuest Robotics Secures $42M in C-1 Financing
FDA Advises Against Use of China-Made Plastic Syringes after Quality Failure Reports

MedRhythms Secures $25M Series B to Advance Digital Therapeutics Platform

What's Next for Artificial Intelligence and Medical Devices?

Better Therapeutics Co-Founder Speaks on SPACs and the Growing PDT Market